STOCKHOLDERS' DEFICIT	9 Months Ended
Sep. 30, 2019
Equity [Abstract]
STOCKHOLDERS' DEFICIT	NOTE-7 STOCKHOLDERS’ EQUITY The Company’s authorized shares are 5,000,000 preferred shares and 70,000,000 common shares with a par value of $0.001 per share. For the nine months ended September 30, 2019, the Company issued 832,000 shares of its preferred stock at $0.001 per share and 24,006,000 shares of its common stock at $0.001 for total proceeds of $24,838. As of September 30, 2019 and December 31, 2018, the Company had a total of 832,000 and 0 shares of its preferred stock issued and outstanding, respectively. As of September 30, 2019 and December 31, 2018, the Company had a total of 29,346,000 and 5,340,000 shares of its common stock issued and outstanding, respectively.

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-URI http://asc.fasb.org/topic&trid=2208762

Name:	us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration